메뉴 건너뛰기




Volumn 23, Issue 5, 2006, Pages 221-226

A dietitian-led lipid clinic is effective

Author keywords

Diabetes; Dietitian; Dyslipidaemia; Protocol

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

EID: 33745781884     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.955     Document Type: Article
Times cited : (6)

References (23)
  • 2
    • 33745772795 scopus 로고    scopus 로고
    • 'Too many, too late'
    • Diabetes UK report. June
    • Diabetes UK report. 'Too many, too late.' June 2001.
    • (2001)
  • 4
    • 0032437504 scopus 로고    scopus 로고
    • Joint British recommendations on prevention of coronary heart disease in clinical practice
    • Wood DA, Durrington P, McInnes G, et al. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80(Suppl): S1-S29.
    • (1998) Heart , vol.80 , Issue.SUPPL.
    • Wood, D.A.1    Durrington, P.2    McInnes, G.3
  • 5
    • 0034715870 scopus 로고    scopus 로고
    • Lipid concentrations and the use of lipid lowering drugs: Evidence from a national cross sectional survey
    • Primatesta P, Poulter N. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ 2000; 321: 1322-1325.
    • (2000) BMJ , vol.321 , pp. 1322-1325
    • Primatesta, P.1    Poulter, N.2
  • 6
    • 0035978089 scopus 로고    scopus 로고
    • Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and 11 in nine countries
    • EUROASPIRE I and II Group
    • EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.
    • (2001) Lancet , vol.357 , pp. 995-1001
  • 7
    • 0043196701 scopus 로고    scopus 로고
    • Socratic dialogue: The future management of hyperlipidaemia
    • Betteridge J. Socratic dialogue: the future management of hyperlipidaemia. Br J Cardiology 2003; 10: S2.
    • (2003) Br J Cardiology , vol.10
    • Betteridge, J.1
  • 9
    • 0642312221 scopus 로고    scopus 로고
    • The implementation of nutritional advice for people with diabetes
    • Nutrition Subcommittee of the Diabetes Care Advisory Committee of Diabetes UK
    • Nutrition Subcommittee of the Diabetes Care Advisory Committee of Diabetes UK The implementation of nutritional advice for people with diabetes. Diabetic Med 2003; 20: 786-807.
    • (2003) Diabetic Med , vol.20 , pp. 786-807
  • 10
    • 0034035191 scopus 로고    scopus 로고
    • Recommendations for the nutritional management of patients with diabetes mellitus
    • Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes
    • Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes. Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutrition 2000; 54: 353-355.
    • (2000) Eur J Clin Nutrition , vol.54 , pp. 353-355
  • 11
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients patients with CHD: The Scandinavian Simvastatin Survival Study (4S)
    • 4S Study Group
    • 4S Study Group. Randomised trial of cholesterol lowering in 4444 patients patients with CHD: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 12
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 13
    • 0025959101 scopus 로고
    • An updated coronary risk profile: A statement for health professionals
    • Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile: a statement for health professionals. Circulation 1991; 83: 356-362.
    • (1991) Circulation , vol.83 , pp. 356-362
    • Anderson, K.M.1    Wilson, P.W.2    Odell, P.M.3
  • 14
    • 0034635812 scopus 로고    scopus 로고
    • Guidelines on preventing cardiovascular disease in clinical practice
    • Jackson R. Guidelines on preventing cardiovascular disease in clinical practice. BMJ 2000; 320: 659-661.
    • (2000) BMJ , vol.320 , pp. 659-661
    • Jackson, R.1
  • 15
    • 33745791327 scopus 로고    scopus 로고
    • Commentary: The lower the better. The real benefits of lowering cholesterol even further
    • Wierzbicki A. Commentary: The lower the better. The real benefits of lowering cholesterol even further. Br J Cardiology 2002; 9: S5-S7.
    • (2002) Br J Cardiology , vol.9
    • Wierzbicki, A.1
  • 16
    • 0038070252 scopus 로고    scopus 로고
    • Current progress in lipid therapy
    • Minhas R. Current progress in lipid therapy. Br J Cardiology 2003; 10: 59-68.
    • (2003) Br J Cardiology , vol.10 , pp. 59-68
    • Minhas, R.1
  • 17
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
    • (2005) Lancet , vol.366 , pp. 1267-1278
  • 18
    • 0035684187 scopus 로고    scopus 로고
    • The National Service Framework for Diabetes and CHD
    • Davies M. The National Service Framework for Diabetes and CHD. Br J Cardiology 2001; 8: S11-S13.
    • (2001) Br J Cardiology , vol.8
    • Davies, M.1
  • 19
    • 21244439123 scopus 로고    scopus 로고
    • This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective levels: A debate
    • Expert panel report
    • Expert panel report. This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective levels: a debate. Br J Cardiology 2005; 12(Suppl 1).
    • (2005) Br J Cardiology , vol.12 , Issue.SUPPL. 1
  • 20
    • 0037309664 scopus 로고    scopus 로고
    • Controlled trial of effect of documented cardiovascular risk scores on prescribing
    • Hall LML, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003; 326: 250-251.
    • (2003) BMJ , vol.326 , pp. 250-251
    • Hall, L.M.L.1    Jung, R.T.2    Leese, G.P.3
  • 21
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • on behalf of the CARDS investigators
    • Colhoun HM, Betteridge DJ, Durrington PN, et al, on behalf of the CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3
  • 22
    • 33644810298 scopus 로고    scopus 로고
    • JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
    • JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl V): v1-v52.
    • (2005) Heart , vol.91 , Issue.SUPPL. V
  • 23
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
    • The FIELD study investigators
    • The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366(9500): 1849-1861.
    • (2005) Lancet , vol.366 , Issue.9500 , pp. 1849-1861


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.